Trial Search

Current Search Criteria:

Intervention: CF101 2 mg
Found 10 matching trials

Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca

PHASE2

This is a Phase 2, randomized, double-masked, placebo-controlled, parallel-...

Status

Completed

Location

Meir Hospital

Start Date

2007-01

Trial ID

NCT00349466

Treatments Being Tested

Safety and Efficacy Study of CF101 to Treat Psoriasis

PHASE2

This study will test the hypothesis that CF101, which is under development ...

Status

Completed

Location

Haemek Medical Center

Start Date

2007-06

Trial ID

NCT00428974

Treatments Being Tested

Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure

PHASE2

This study will test the hypothesis that CF101, administered orally, will r...

Status

Completed

Location

Specialized Hospital for Active Treatment for Eye Diseases "Zrenie"

Start Date

2010-10

Trial ID

NCT01033422

Treatments Being Tested

Safety &Efficacy of CF101 to Subjects With Uveitis

PHASE2

This is a Phase 2, randomized, double-masked, placebo-controlled study subj...

Status

Withdrawn

Location

Bnei-Zion Medical Center

Start Date

2019-01

Trial ID

NCT01905124

Treatments Being Tested

CF101 Therapy Compared to Methotrexate Therapy for Active Rheumatoid Arthritis

PHASE3

This trial will test the hypothesis that the administration of CF101, a nov...

Status

Terminated

Location

Can-Fite Investigational Site #252

Start Date

2017-10-30

Trial ID

NCT02647762

Treatments Being Tested

Piclidenoson for Treatment of COVID-19

PHASE2

Patients with documented moderate COVID-19 infection will be randomized 1:1...

Status

Completed

Location

II Multiprofile Hospital for Active Treatment - Sofia EAD

Start Date

2021-01-06

Trial ID

NCT04333472

Treatments Being Tested

A Study of the Efficacy and Safety of CF101 to Patients With Osteoarthritis of the Knee

PHASE2

This study will test the effectiveness of CF101 in treating the symptoms of...

Status

Withdrawn

Location

Barzilai Medical Center

Start Date

2018-11

Trial ID

NCT00837291

Treatments Being Tested

Trial of CF101 to Treat Patients With Psoriasis

PHASE2

Eligible patients with Psoriasis will be treated with CF101 or placebo twic...

Status

Completed

Location

Mount Sinai School of Medicine

Start Date

2011-07

Trial ID

NCT01265667

Treatments Being Tested

An Open-label, Phase 2 Pilot Study on the Efficacy and Safety of Piclidenoson in Patients With Lowe Syndrome

PHASE2

The primary objective of this trial is to: 1\. Evaluate the efficacy of pi...

Status

Not Yet Recruiting

Location

IRCCS Ospedale Pediatrico Bambino Gesù

Start Date

2026-06-01

Trial ID

NCT07410455

Treatments Being Tested

Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients

PHASE2

This trial will test the hypothesis that the addition of CF101, a novel ant...

Status

Completed

Location

Clinic of Rheumatology at MHAT 'Sveti Georgi'

Start Date

2008-02

Trial ID

NCT00556894

Treatments Being Tested